Pricing

U.S. District Judge Eldon Fallon Given Oversight Of Consolidated Xarelto Lawsuit Cases

Download as PDF Single Release RSS Feed
Facebook Twitter Reddit LinkedIn Email

TheProductLawyers.com reports on a hearing convened by the U.S. Judicial Panel for Multidistrict Litigation (JPML) addressing a request by a group of plaintiffs dated October 2015. The plaintiffs all allege that they or loved ones used Xarelto and had suffered from dangerously uncontrollable bleeding while taking the blood thinner. The group requested to have the over 2,800 similar cases to be litigated as a group since all were filed against the same defendants and possessed very similar allegations.

In a decision dated December 12, 2015, the consolidation was granted by the panel and it appointed U.S. District Judge Eldon E. Fallon of the Eastern District of Louisiana to oversee the federally-filed cases. The panel stated that Judge Fallon was willing and able to preside over the Multidistrict Litigation (MDL) and had the experience necessary to monitor a multidistrict litigation process. It also concurred that given the number of cases involving the same defendants with similar claims against them, that such informal coordination of the multitude of pending cases was impractical.

Since the multidistrict consolidation was announced the number of cases has escalated and is expected to continue to increase while the cases involved in the initial MDL await trial. The consolidation process will facilitate a much more streamlined litigation process since it will allow for non-duplicative discovery processes and having to deal with numerous conflicting rulings by different judges across the country. The MDL will also lessen overall litigation costs and the time spent by the parties involved to prepare for each individual case.

Defendants in all of the consolidated cases include Bayer AG and the subsidiary of the Johnson and Johnson Corporation, Janssen Pharmaceuticals. Since the defendants are located in New Jersey, they were opposed to the consolidation of the cases in the Southern District of Illinois and asked that the cases be transferred to New Jersey.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-478-9711.

Download as PDF Single Release RSS Feed
Facebook Twitter Reddit LinkedIn Email

About TheProductLawyers.com :

TheProductLawyers.com is a resource website sponsored by Banville Law to provide information on pending lawsuits against defective products, drugs and medical devices.

Contact TheProductLawyers.com:

Banville Law

165 West End Ave #1h,
New York, NY 10023

888-478-9711

Additional News Releases From TheProductLawyers.com:

November 30, 2016Research Indicates New Form Of Treating Ovarian Cancer As Talcum Powder Lawsuit Numbers Climb

November 30, 2016Parties in Talcum Powder Lawsuit In Missouri Exchange Briefings

November 30, 2016J&J Requests Disclosure Of Third Party Litigation Financing In Talcum Powder Lawsuit

November 30, 2016Delaware Sees 10 New Talcum Powder Lawsuit Filings

November 29, 2016Philadelphia Talcum Powder Lawsuit Filed Against Johnson & Johnson To Proceed

November 29, 2016Pennsboro Woman Files Talcum Powder Lawsuit On Behalf Of Her Deceased Mother

November 29, 2016Bioimaging Helps Early Detection Of Ovarian Cancer As Talcum Powder Lawsuit Filings Continue

November 28, 2016FDA Follow-Up: How Officials Have Responded To The Influx Of Talcum Powder Lawsuit Filings

November 28, 2016Talc Uses: A Look At The Product At The Center Of Talcum Powder Lawsuit Filings

November 28, 2016More Women Encouraged To File A Talcum Powder Lawsuit After Verdicts